Pulmocide
Novel therapies for patients suffering from serious acute and chronic respiratory diseases.
Invested: 2021
Modality: Inhaled Therapeutic
Website: pulmocide.com
portfolio
Excision BioTherapeutics
CRISPR-based therapies for chronic viral infectious diseases such as HIV and hepatitis B.
Invested: 2021
Modality: Therapeutic
Website: excision.bio
Frontier Nutrition
Fortified snacks to address maternal and childhood malnutrition in Bangladesh.
Invested: 2020
Modality: Lipid-Based Nutritional Supplements (LNS)
Website: frontiernutrition.com
VitriVax
Thermostability and pulsatile dosing technology for vaccines and other sensitive biologics.
Invested: 2020
Modality: Vaccine
Website: vitrivaxbio.com
MinvervaX
Group B Streptococcal vaccine for the prevention of life-threatening infections in newborns.
Invested: 2020
Modality: Vaccine
Website: minervax.com
Evofem
Woman-controlled, non-hormonal contraceptive.
Invested: 2020
Modality: Contraceptive
Website: evofem.com
Univercells
Univercells uses advanced manufacturing technologies to make "Biologics for all."
Invested: 2020
Modality: Process Innovation
Website: univercells.com
Yisheng Biopharma
Yisheng is scaling up undersupplied global health vaccines and developing innovative new biologics.
Invested: 2020
Modality: Vaccine
Website: yishengbio.com
ChromaCode
ChromaCode's HD-PCR technology enhances multiplexing capabilities on existing hardware.
Invested: 2020
Modality: Platform
Website: chromacode.com
54gene
54gene is using African genetic data to drive discoveries in drug and vaccine development.
Invested: 2020
Modality: Platform
Website: 54gene.com
Codagenix
Codagenix uses emerging computational and synthetic biology tools to rationally design vaccines.
Invested: 2020
Modality: Platform
Website: codagenix.com
AN2 Therapeutics
AN2 is developing novel, broad-spectrum therapeutics for infectious diseases.
Invested: 2019
Modality: Small Molecule
Website: an2therapeutics.com
Themis
Themis is developing novel vaccines for high burden infectious diseases and oncology applications.
Invested: 2019
Modality: Vaccine
Website: themisbio.com
InDevR
InDevR is developing advanced characterization assays for biologics.
Invested: 2019
Modality: Process Innovation
Website: indevr.com